Latest 8-K filings

Calidi Biotherapeutics announced positive FDA feedback for CLD-401, advanced its RedTail platform with new data, and reduced G&A expenses in its Q2 2026 report.

Nauticus Robotics, Inc. has entered into a Fourth Amendment to its Term Loan Agreement, further reducing the conversion price of the loan.

Spruce Power Holding Corporation announced second quarter 2026 results, showcasing a 10% year-over-year increase in operating income and a shift to net income attributable to stockholders.

ContextLogic Holdings Inc. announced its second-quarter 2026 financial results, reporting flat revenue of $33.6 million but a significant increase in net loss to $6.3 million, impacted by corporate expenses and acquisition amortization.

Entrepreneur Universe Bright Group reported a significant decrease in revenue and a net loss for the second quarter of 2026, contrasting with a profitable period in the prior year.

Boston Omaha Corporation announced its second quarter 2026 financial results, showing modest revenue growth and improved operational cash flow, alongside progress on the sale of its insurance subsidiary.

Arizona Public Service Company has entered into an underwriting agreement to issue $100 million in 5.50% Notes due 2035 and $600 million in 6.25% Notes due 2056.

SmartStop Self Storage REIT, Inc. presented its Q2 2026 investor materials, detailing 'The Deca Initiative' for growth, strong operational metrics, and a diversified portfolio across the U.S. and Canada.

Professional Diversity Network, Inc. announced the pricing of its public offering of 7,144,000 units at $0.28 per unit, raising approximately $2.0 million.

Aptevo Therapeutics announced the closing of a transaction involving the exercise of existing warrants and a private placement, raising approximately $4.5 million in gross proceeds.

Adagio Medical Holdings, Inc. provided an updated corporate presentation detailing advancements in its Ultra Low Temperature Cryoablation (ULTA) technology for Ventricular Tachycardia (VT) ablation, with key regulatory milestones and product launches on the horizon.

NextNRG announced robust second quarter 2026 financial results, showcasing a 41% year-over-year revenue increase to $27.7 million, an 82% reduction in net loss, and a 62% narrowing of Adjusted EBITDA loss.

Tempest Therapeutics reported Q2 2026 financial results, highlighting a new development collaboration for TPST-4003, positive interim data for TPST-2003, and strategic board appointments.

Health In Tech, Inc. presented an investor deck on August 13, 2026, detailing its AI-powered marketplace for SMB self-funded health plans, while acknowledging recent revenue declines and net losses.

Health In Tech announced its second quarter 2026 financial results, reporting a decrease in revenue and a net loss, though it highlighted growth in distribution partners and a substantial revenue pipeline.

Firy Inc. announced its second quarter 2026 financial results, highlighting a 23% year-over-year revenue increase and a significant legal win against Papaya Gaming, though net losses persist.

AbCellera Biologics Inc. announced the pricing of an oversubscribed public offering of common shares and pre-funded warrants, raising approximately $200 million to fund its internal pipeline and general corporate purposes.

The Bank of New York Mellon Corporation announced the election of Vikram Malhotra, a seasoned McKinsey & Company senior partner, as an independent director to its Board, effective October 1, 2026.

Innventure, Inc. announced its second quarter 2026 results, suspending previously communicated revenue and cash flow targets for Accelsius to focus on foundational milestones for two-phase liquid cooling adoption.

KIDZ AI Inc. announced its second quarter 2026 financial results, reporting a narrowed net loss, a significantly improved capital structure, and progress on its AI infrastructure build-out.

Inflection Point Acquisition Corp. V has extended its business combination deadline to December 31, 2026, following shareholder approval, while also experiencing substantial share redemptions.

Tempest Therapeutics has entered into a $50 million purchase agreement with Lincoln Park Capital Fund, LLC, providing a flexible equity financing option.

Gemini Space Station, Inc. announced Q2 2026 financial results, showing a 37% year-over-year revenue increase to $45.5 million, driven by services revenue, while net loss widened.

Tyson Foods announces a strategic restructuring of its beef business, including the closure of two facilities and the sale of another, to optimize its network amidst cattle supply shortages.

XBP Global Holdings reported a Q2 2026 with a revenue decline but notable improvements in profitability metrics and strong contract value growth.

BlackSky Technology Inc. received a NYSE notice regarding the commencement of delisting proceedings for its warrants due to abnormally low selling prices.

Net Power recalibrates its strategy to focus on fast-to-deploy, unabated natural gas power generation to meet accelerating demand from AI and data centers, while retaining carbon capture as a future option.

Xylem Inc. announced the appointment of D. Christian Koch to its Board of Directors, expanding the board to ten members and adding significant leadership experience.

CAMP4 Therapeutics announced Q2 2026 results, highlighting regulatory clearance for its CMP-002 Phase 1/2 trial in SYNGAP1 patients and securing $50.1 million in funding, extending cash runway to end of 2028.

GrabAGun Digital Holdings Inc. announces the retirement of CFO Justin Hilty and the appointment of Jonathan Terry, a seasoned finance executive, to lead the company's next growth phase.